Back to Search
SUZANNE TOPALIAN, M.D.
M.D.
Surgery Physician
NPI: 1083664684Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy.
PMID 19581576·Proc Natl Acad Sci U S A·2009
8-other
Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas.
PMID 18477896·Melanoma Res·2008
8-other
Natriuretic peptides: biomarkers not predictive in the intensive care unit.
PMID 17413786·Crit Care Med·2007
8-other
Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor.
PMID 17334368·Nat Immunol·2007
8-other
Cancer regression in patients after transfer of genetically engineered lymphocytes.
PMID 16946036·Science·2006
3-trial
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
PMID 16710025·J Clin Oncol·2006
8-other
Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.
PMID 16638862·Clin Cancer Res·2006
3-trial
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
PMID 16283570·Ann Surg Oncol·2005
3-trial
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.
PMID 16237114·J Immunol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 N WOLFE ST, BLALOCK 655
BALTIMORE, MD 21287 - Phone
- (410) 955-6796
Quick Facts
- NPI
- 1083664684
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile